PURPOSE: Arylamino fused pyridines and pyrimidines are provided to be used for treating a mind impediment or a neurological disease including a melancholia, an uneasiness-related impediment, a stress after an external wound, a supranuclear palsy, and an ingestion impediment. CONSTITUTION: Corticotropin releasing factor (CRF) antagonists of formula (I) or formula(II): and their use in treating anxiety, depression, and other psychiatric and neurological disorders.
ARYLAMINO FUSED PYRIDINES AND PYRIMIDINES